Investing in the Future of Elysia
Elysia is pleased to welcome a new industrial shareholder. This partnership provides a solid foundation for sustainable growth, enhanced innovation, and long-term financial strength.
Elysia-Raytest joins a portfolio of specialist businesses within Paradigm Group Holdings, including LabLogic, Southern Scientific, BriTec, Knight Imaging and Care Wise.
The acquisition strengthens the Group's capabilities across software, instrumentation, radiopharmaceutical production, quality control, radiation detection and laboratory technologies. The Group sees significant opportunities for collaboration in research, development and innovation, particularly as demand continues to grow in areas such as theranostics, radiopharmaceutical manufacturing and targeted alpha therapies.
LabLogic and Elysia-Raytest will continue to operate through their established brands, customer relationships, management teams and commercial organisations. The Group recognises the importance of maintaining appropriate commercial separation and will continue to operate in accordance with applicable competition, procurement and regulatory requirements in all markets it serves.
The priority throughout this process remains supporting customers, suppliers, employees and partners while investing in the long-term development of both organisations.
John Clapham, Director of Paradigm Group Holdings, said, "This acquisition is about strengthening our long-term ability to invest in technology, capability and innovation. Elysia-Raytest have deep expertise in radiopharmaceuticals and nuclear medicine, and we believe there is significant potential to accelerate development by working more closely together. As the industry continues to evolve, particularly with the ongoing development of alpha-emitting radionuclides, it is important that we continue investing in the technologies and expertise our customers will need in the future."
Daniel Bartholemy, Co-Founder of Elysia-Raytest, added, "For Elysia-Raytest, joining the Paradigm Group provides long-term stability and access to additional resources whilst allowing us to maintain our brand, culture and close relationships with customers. Our team remains focused on delivering the products, support and expertise our customers rely upon every day, and we look forward to contributing to the future growth and success of the wider Group."
------------
About Paradigm Group Holdings
Paradigm Group Holdings Co is an employee-owned group that owns and supports a portfolio of specialist businesses including LabLogic, Southern Scientific, BriTec, Knight Imaging, Care Wise and Elysia-Raytest. Through its Employee Ownership Trust structure, the Group takes a long-term approach to investment, innovation and business development, supporting customers across scientific, healthcare and highly regulated industrial markets worldwide.
